Company news

Correvio Pharma Corp news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Correvio Obtains Final Order for Plan of Arrangement

May 21, 2020

Correvio Announces Results from Annual General and Special Meeting of Securityholders

May 15, 2020

Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA

May 6, 2020

Correvio Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19

May 4, 2020

Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA

May 1, 2020

Correvio Obtains Interim Order For Plan Of Arrangement

April 8, 2020

Correvio Reports Full Year 2019 Financial Results

March 30, 2020

ADVANZ PHARMA to Acquire Correvio

March 16, 2020

Correvio Partners with Hong Kong Teson Pharma Limited for the Commercialization of Aggrastat® in China

March 10, 2020

Correvio Responds to Market Activity

March 2, 2020

Correvio Receives NASDAQ Notification Regarding Deficiencies In Minimum Bid Price And Market Value Of Listed Securities

January 28, 2020

Correvio Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events

December 24, 2019

Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value

December 11, 2019

Correvio Announces Outcome Of FDA Advisory Committee Meeting Reviewing Brinavess(TM) For The Treatment Of Recent Onset Atrial Fibrillation

December 10, 2019

Correvio Stock Trading Halted Today; FDA Advisory Committee Meeting To Discuss Brinavess(TM) For Recent Onset Atrial Fibrillation

December 10, 2019

Correvio to Present at the Piper Jaffray 31st Annual Healthcare Conference

November 25, 2019

Correvio Announces Presentation of New Brinavess(TM) Spectrum Data at the American Heart Association 2019 Annual Meeting

November 18, 2019

Correvio Reports Third Quarter 2019 Financial Results

November 14, 2019

Correvio Announces FDA Advisory Committee Meeting to Review Brinavess(TM) for Recent Onset Atrial Fibrillation

November 4, 2019

Correvio to Present at the 2019 Cantor Global Healthcare Conference

September 27, 2019

Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent New Drug Application

September 12, 2019

Correvio to Present at the H.C. Wainwright 21st Annual Global Investment Conference

September 4, 2019

Correvio Announces Presentation Of Brinavess® Spectrum Data At The European Society Of Cardiology 2019 Congress

September 3, 2019

Correvio Reports Second Quarter 2019 Financial Results

August 14, 2019

Correvio Announces Brinavess® Spectrum Data to be Presented at the European Society of Cardiology 2019 Congress

August 12, 2019

Correvio to Report Second Quarter 2019 Financial Results

August 8, 2019

Correvio Closes Public Offering of 9,200,000 Common Shares

August 7, 2019

Correvio Announces Pricing Of Public Offering Of Common Shares

August 2, 2019

Correvio Announces Overnight Marketed Offering of Common Shares

August 1, 2019

U.S. FDA Accepts Correvio's Resubmitted New Drug Application For Brinavess (vernakalant)

July 25, 2019

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

Correvio Announces Voting Results

June 18, 2019

Correvio Reports First Quarter 2019 Financial Results

May 8, 2019

Correvio to Report First Quarter 2019 Financial Results on May 8, 2019

May 1, 2019

Correvio Announces Zevtera® Abstracts at ECCMID 2019

April 3, 2019

Correvio Announces Xydalba(TM) (Dalbavancin Hydrochloride) Abstracts at ECCMID 2019

April 3, 2019

Correvio to present at the H.C. Wainwright Global Life Sciences Conference

April 2, 2019

Correvio Announces Presentation Of Brinavess® Data At The American College Of Cardiology 2019 Annual Meeting

March 20, 2019

Correvio Announces at the Market Offering

March 14, 2019

Correvio Reports Fourth Quarter and Full Year 2018 Financial Results

March 13, 2019

Correvio Announces Amendment To Term Loan With CRG-Managed Funds

March 11, 2019

Correvio to Present at Upcoming Investor Conferences

March 7, 2019

Correvio To Report Fourth Quarter And Full Year 2018 Financial Results On March 13, 2019

March 6, 2019

Correvio to Participate in the 8th Annual SVB Leerink Global Healthcare Conference

February 21, 2019

Correvio Announces Presentation Of Brinavess Data At Belgian Society Of Cardiology 2019 Annual Congress

February 7, 2019

Correvio Provides Update On At The Market Offering

January 17, 2019

Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes

January 2, 2019

Correvio to Present at the 30th Annual Piper Jaffray Healthcare Conference

November 20, 2018

Correvio Reports Third Quarter 2018 Financial Results

November 6, 2018

Correvio to Report Third Quarter 2018 Financial Results on November 6, 2018

October 30, 2018

Older news releases →

Decks